fluorine F 18 EF5

RADIATION3 trials

Sponsors

National Cancer Institute (NCI), Abramson Cancer Center at Penn Medicine

Conditions

Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic OligodendrogliomaAdult Brain Stem GliomaAdult Central Nervous System Germ Cell TumorAdult Choroid Plexus TumorAdult CraniopharyngiomaAdult Diffuse Astrocytoma

Phase 1

Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors

TerminatedNCT00110032

National Cancer Institute (NCI)Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma +24

Start: 2005-06-30Updated: 2013-01-16

Fluorine F18-EF5 and Fludeoxyglucose F18 Positron Emission Tomography in Assessing Hypoxia and Glycolysis in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

CompletedNCT01017133

Abramson Cancer Center at Penn MedicineNon-small Cell Lung Cancer

Start: 2009-05-31End: 2012-09-30Target: 56Updated: 2012-09-26

Unknown Phase

Fluorine F 18 EF5 PET/CT Imaging in Patients With Locally Advanced or Recurrent/Metastatic Cervical Cancer

TerminatedNCT00978874

Abramson Cancer Center at Penn MedicineCervical Cancer

Start: 2008-05-31End: 2013-09-04Updated: 2021-06-25